CN Stock MarketDetailed Quotes
603567 HeiLongJiang ZBD Pharmaceutical
- 11.96
- -0.22-1.81%
Not Open Dec 13 15:00 CST
11.26BMarket Cap17.23P/E (TTM)
12.22High11.95Low138.17KlotVolume12.15Open12.18Pre Close167.18MTurnover1.47%Turnover Ratio23.82P/E (Static)941.14MShares13.6352wk High1.45P/B11.24BFloat Cap8.6952wk Low13.40Limit Up939.54MShs Float58.82Historical High10.96Limit Down2.22%Amplitude8.69Historical Low0.20Dividend TTM12.10Avg Price91.84KlotAsk1.67%Div YieldTTM100Lot Size43.72KlotBid
HeiLongJiang ZBD Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -1.09%2.03B | 7.02%1.66B | -11.62%1.12B | -25.50%3.14B | -38.21%2.05B | -37.40%1.55B | 25.92%1.27B | 2.17%4.22B | 22.77%3.32B | 52.18%2.48B |
| Operating revenue | -1.02%2.03B | 7.10%1.66B | -11.59%1.12B | -25.53%3.14B | -38.25%2.05B | -37.44%1.55B | 25.91%1.26B | 2.12%4.21B | 22.70%3.32B | 52.06%2.48B |
| Other operating revenue | ---- | -66.71%7.93M | ---- | 268.58%54.11M | ---- | 428.28%23.82M | ---- | 125.82%14.68M | ---- | 40.80%4.51M |
| Interest income | -38.59%2.19M | -40.68%1.62M | -38.08%843.67K | 1.38%5.33M | -8.83%3.57M | 5.26%2.74M | 31.64%1.36M | 67.32%5.25M | 125.46%3.91M | 524.36%2.6M |
| Total operating cost | -27.24%1.52B | -35.99%1.1B | -28.80%680.92M | -34.03%3.07B | -34.67%2.08B | -22.08%1.73B | 12.34%956.3M | 16.51%4.66B | 25.32%3.19B | 52.49%2.21B |
| Operating cost | -15.48%950.73M | -33.65%697.6M | -21.10%462.11M | -47.88%1.81B | -53.00%1.12B | -38.04%1.05B | -2.96%585.7M | 25.73%3.47B | 49.67%2.39B | 110.15%1.7B |
| Operating tax surcharges | 34.84%40.77M | 54.08%29.57M | 91.91%17.12M | -1.60%43.79M | -12.15%30.24M | -6.64%19.19M | -1.91%8.92M | -31.94%44.51M | -31.04%34.42M | -45.89%20.56M |
| Operating expense | -65.16%195.18M | -60.87%162.33M | -60.26%99.64M | 9.85%668.24M | 44.54%560.27M | 66.13%414.87M | 126.20%250.72M | -5.62%608.31M | -23.40%387.61M | -29.77%249.72M |
| Administration expense | -0.81%220.82M | -2.14%146.97M | 11.31%71.95M | 3.63%333.66M | -4.70%222.62M | -3.32%150.18M | -23.78%64.64M | -0.86%321.99M | -5.94%233.6M | -1.44%155.34M |
| Financial expense | -5.88%93.33M | -12.49%57.33M | -19.05%26.13M | -0.65%134.45M | 0.67%99.16M | 0.16%65.51M | 0.94%32.28M | -5.04%135.32M | -6.67%98.49M | -5.16%65.4M |
| -Interest expense (Financial expense) | 2.46%103.95M | 4.85%69.92M | 9.50%35.42M | -2.36%135.41M | -1.70%101.46M | -3.49%66.68M | -3.27%32.35M | -4.22%138.68M | -4.30%103.21M | -2.89%69.1M |
| -Interest Income (Financial expense) | -535.68%-17.74M | -639.14%-13.05M | -986.83%-9.51M | 60.68%-2.49M | 48.10%-2.79M | 55.84%-1.77M | 46.17%-874.72K | -17.90%-6.33M | -51.68%-5.38M | -59.12%-4M |
| Research and development | -66.55%15.79M | -56.28%10.53M | -71.81%3.96M | 13.07%80.22M | 9.25%47.21M | -8.52%24.08M | 27.41%14.04M | 28.46%70.95M | 16.21%43.22M | 7.76%26.32M |
| Credit Impairment Loss | -10.00%-50.46M | -166.20%-47.16M | -10.28%-59.08M | -258.08%-95.11M | -289.83%-45.87M | -583.23%-17.72M | -861.72%-53.58M | 194.46%60.16M | 156.22%24.17M | 114.68%3.67M |
| Asset Impairment Loss | -505.56%-60.66M | -19.12%-45.18M | -4,395.91%-22.71M | 71.48%-14.48M | 65.01%-10.02M | -194.62%-37.93M | 105.23%528.58K | -5.19%-50.79M | 0.14%-28.63M | -332.67%-12.87M |
| Other net revenue | -126.92%-73.19M | -121.77%-57.62M | -126.90%-73.68M | -45.36%400.97M | 196.28%271.84M | 407.66%264.68M | -191.58%-32.47M | 127.77%733.83M | -33.51%91.75M | -69.18%52.14M |
| Fair value change income | 158.82%45.92K | 138.10%18.37K | 381.82%71.17K | 92.61%-78.06K | 93.26%-78.06K | 95.24%-48.21K | -121.20%-25.25K | ---1.06M | ---1.16M | ---1.01M |
| Invest income | -103.96%-4.77M | -94.91%6.24M | -857.93%-5.13M | 1,652.10%463.86M | 3,381.69%120.21M | 636.46%122.59M | -96.86%677.08K | -89.10%26.47M | -97.72%3.45M | -88.50%16.65M |
| -Including: Investment income associates | 47.58%-18.52M | 71.46%-7.51M | 73.44%-5.13M | -42.90%-24.39M | 2.05%-35.32M | -10.69%-26.32M | -136.22%-19.32M | 42.66%-17.07M | -123.62%-36.06M | -75.65%-23.78M |
| Asset deal income | -100.88%-1.51M | -100.44%-752.93K | 3,932.18%147.5K | -100.66%-261.79K | 355.21%171M | 94,698.99%171M | 577.61%3.66K | 4,523.58%39.52M | 55,131.98%37.57M | -15,143.98%-180.77K |
| Other revenue | 20.71%44.17M | 9.13%29.22M | -34.64%13.02M | -92.87%47.04M | -35.06%36.59M | -41.66%26.77M | -32.67%19.92M | 243.09%659.52M | -2.69%56.35M | 4.72%45.89M |
| Operating profit | 83.78%439.58M | 439.14%500.29M | 31.55%363.54M | 59.06%473.24M | 7.94%239.19M | -70.94%92.79M | 46.31%276.34M | -34.77%297.53M | -25.30%221.59M | -8.15%319.34M |
| Add:Non operating Income | -0.55%1.89M | 7.86%1.57M | 1.57%750.59K | 56.30%8.29M | 50.87%1.9M | 60.30%1.46M | 38.70%738.99K | 16.15%5.3M | -61.06%1.26M | -56.74%910.02K |
| Less:Non operating expense | 35.92%2.79M | -72.69%195.04K | -94.10%30.25K | -26.61%3.19M | -46.96%2.05M | 12.80%714.25K | -6.03%512.73K | -26.79%4.35M | 261.78%3.86M | -33.94%633.19K |
| Total profit | 83.52%438.69M | 436.32%501.67M | 31.71%364.26M | 60.26%478.35M | 9.16%239.04M | -70.73%93.54M | 46.44%276.57M | -34.36%298.48M | -26.71%218.99M | -8.37%319.62M |
| Less:Income tax cost | 97.59%42.25M | 1,143.73%106.65M | 79.45%70.99M | -90.00%10.76M | -64.03%21.38M | -113.36%-10.22M | 27.78%39.56M | -11.83%107.55M | 9.35%59.45M | 7.61%76.47M |
| Net profit | 82.14%396.43M | 280.72%395.02M | 23.74%293.27M | 144.90%467.59M | 36.43%217.65M | -57.33%103.76M | 50.09%237.01M | -42.62%190.93M | -34.73%159.53M | -12.46%243.15M |
| Net profit from continuing operation | 82.14%396.43M | 280.72%395.02M | 23.74%293.27M | 144.90%467.59M | 36.43%217.65M | -57.33%103.76M | 50.09%237.01M | -42.62%190.93M | -34.73%159.53M | -12.46%243.15M |
| Less:Minority Profit | -327.45%-1.3M | 119.02%1.69M | -122.22%-92.96K | -193.89%-5.15M | -90.55%570.95K | -80.69%770.22K | 663.69%418.3K | 731.70%5.49M | 199.58%6.04M | 171.24%3.99M |
| Net profit of parent company owners | 83.22%397.73M | 281.93%393.33M | 24.00%293.37M | 154.93%472.74M | 41.43%217.08M | -56.94%102.99M | 49.76%236.59M | -44.16%185.44M | -36.68%153.5M | -13.43%239.16M |
| Earning per share | ||||||||||
| Basic earning per share | 83.17%0.4233 | 282.03%0.4187 | 24.84%0.3121 | 155.43%0.5032 | 41.78%0.2311 | -56.83%0.1096 | 47.06%0.25 | -48.71%0.197 | -42.91%0.163 | -21.95%0.2539 |
| Diluted earning per share | 82.86%0.4226 | 281.39%0.418 | 24.84%0.3121 | 155.28%0.5029 | 41.78%0.2311 | -56.83%0.1096 | 47.06%0.25 | -48.71%0.197 | -42.91%0.163 | -21.95%0.2539 |
| Other composite income | -492.86%-415K | 233.22%189.1K | -70K | -141.95K | ||||||
| Other composite income of parent company owners | ---- | -492.86%-415K | ---- | 233.22%189.1K | ---- | ---70K | ---- | ---141.95K | ---- | ---- |
| Total composite income | 82.14%396.43M | 280.57%394.6M | 23.74%293.27M | 145.18%467.78M | 36.43%217.65M | -57.36%103.69M | 50.09%237.01M | -42.66%190.79M | -34.73%159.53M | -12.46%243.15M |
| Total composite income of parent company owners | 83.22%397.73M | 281.78%392.92M | 24.00%293.37M | 155.23%472.93M | 41.43%217.08M | -56.97%102.92M | 49.76%236.59M | -44.20%185.3M | -36.68%153.5M | -13.43%239.16M |
| Total composite income of minority owners | -327.45%-1.3M | 119.02%1.69M | -122.22%-92.96K | -193.89%-5.15M | -90.55%570.95K | -80.69%770.22K | 663.69%418.3K | 731.70%5.49M | 199.58%6.04M | 171.24%3.99M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion with explanatory notes | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Zhongzhun Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhongzhun Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
